SCHEMBL2179801

SCHEMBL2179801

CNc1nccc(-c2cc(NC(=O)CN3CCN(CC(=O)N4CCOCC4)CC3)c3cc(OC)ccc3c2)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.44
HPGD P15428 2/20 0.44
HSD17B10 Q99714 2/20 0.44
KDM4E B2RXH2 2/20 0.44
ALOX15 P16050 1/20 0.44
HTT P42858 1/20 0.44
KMT2A Q03164 2/20 0.42
GSK3B P49841 2/20 0.42
DYRK1A Q13627 2/20 0.42
PTGS2 P35354 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.41
MTNR1A P48039 1/20 0.41
MTNR1B P49286 1/20 0.41
KDR P35968 2/20 0.41
CCNE2 O96020 1/20 0.40
CDK4 P11802 1/20 0.40
CCND1 P24385 1/20 0.40
CCNE1 P24864 1/20 0.40
CDK2 P24941 1/20 0.40
MTOR P42345 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2181492 0.93 KMT2A (0.46) ALDH1A1HPGDHSD17B10KDM4EKMT2A
SCHEMBL2179190 0.93 KMT2A (0.41) ALDH1A1KMT2APTGS2KDRCCNE2
SCHEMBL2177870 0.92 PTGS2 (0.41) ALDH1A1KDM4EKMT2APTGS2KDR
SCHEMBL2181105 0.91 MAPK13 (0.46) ALDH1A1HPGDHSD17B10KDM4EKMT2A
SCHEMBL2184977 0.88 KDR (0.42) ALDH1A1KDM4EKMT2AKDRCCNE2
SCHEMBL2178573 0.87 TP53 (0.45) ALDH1A1KDM4EALOX15KMT2AKDR
SCHEMBL2179634 0.86 TSHR (0.46) ALDH1A1KDM4EHTTKMT2A
SCHEMBL2180704 0.86 ATM (0.46) ALDH1A1KDM4EHTTKMT2AL3MBTL1
SCHEMBL2179087 0.86 KMT2A (0.42) ALDH1A1HPGDKDM4EHTTKMT2A
SCHEMBL2180895 0.86 KCNA5 (0.43) ALDH1A1KMT2AGSK3BKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US claimed
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US disclosed
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US disclosed
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds ARQULE, INC. (US) 2011-07-07 US disclosed
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds ARQULE, INC. (US) 2011-07-07 US disclosed
WO-2011082268-A2 SUBSTITUTED NAPHTHALENYL-PYRIMIDINE COMPOUNDS ARQULE INC. (US) 2011-07-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds DPYD, TP53, TYMP ALDH1A1 619/4885HPGD 225/4885HSD17B10 2943/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.